1. India Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Arvaya Healthcare Ltd

Arvaya Healthcare Ltd

BBSE:ARVAYA
102.75
INR
+2.00
(+1.99%)
0.40EPS
216.87P/E
3.23BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1.09
1.64
1.42
4.38
1.46
1.33
1.64
1.34
1.09
1
0.93
0.92
7.49
10.25
Basic EPS, GAAP
0.12
0.01
-0.18
-0.43
-0.38
-0.27
-0.18
-0.3
-0.63
-1.48
-0.39
0.45
0.7
0.31
Free Cash Flow per Basic Share
-0.34
0.55
-0.76
-1.76
-0.52
0.08
-0.27
-0.06
-1.23
-1.25
-0.98
0.72
-7.84
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
15.83
15.84
15.36
14.93
14.55
14.28
14.1
13.8
13.18
11.7
11.31
11.76
12.47
- -
Tangible Book Value per Share
15.83
15.84
15.36
14.93
14.55
14.28
14.1
13.8
13.18
11.7
11.31
11.76
6.57
- -
Basic Weighted Avg Shares
3
2
3
3
3
3
3
3
3
3
3
3
10
38
Sales/Revenue/Turnover
3
4
4
13
4
4
5
4
3
3
3
3
76
390
Operating Margin (%)
-68.71
-83.93
-75.2
-26.79
-81.17
-77.1
-57.26
-72.86
-103.32
-127.04
-147.81
-189.72
5.53
5.12
Depreciation Expense
1
1
1
1
1
1
- -
- -
- -
1
- -
- -
6
28
Net Income, GAAP
- -
- -
-1
-1
-1
-1
-1
-1
-2
-4
-1
1
7
12
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
28.65
17.38
12.45
Profit Margin (%)
10.98
0.61
-12.67
-9.82
-25.87
-20.25
-10.95
-22.02
-57.67
-148.23
-41.88
49.44
9.35
3.02
Working Capital
35
37
36
34
33
34
30
28
28
17
18
29
54
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
435
- -
Total Equity
48
48
46
45
44
43
42
41
40
35
34
35
631
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.22
0.18
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4.05
1.44
- -
Return on Common Equity (%)
0.76
0.05
-1.15
-2.87
-2.56
-1.86
-1.27
-2.12
-4.65
-11.9
-3.4
3.93
2.24
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
59
- -
LT Borrowings
- -
80
- -
LT Finance Leases
- -
354
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
48
48
48
Market Capitalization
- -
- -
3,226

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
381
- -
Cash, Cash Equivalents & STI
- -
24
- -
Accounts Receivable, Net
- -
22
- -
Inventories
- -
19
- -
Total Current Liabilities
- -
327
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
59
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
166.2%
334.51%
1,687.67%
Free Cash Flow
-249.13%
-380.13%
-3,777.02%
Net Income, GAAP
51.07%
75.84%
420.94%
Sales/Revenue/Turnover
276.13%
523.95%
2,655.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1
1
1
- -
3
2026
- -
- -
- -
91
76
2027
299
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.17
-0.47
1.78
-0.68
0.45
2026
-0.34
-0.41
-0.03
0.26
0.7
2027
0.08
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
Sector
Distribution services
Industry
Medical distributors
Address
Miraj India
IPO Date
Jul 18, 2005
Website
bijoyhans.net
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Arvaya Healthcare Ltd is an India-based healthcare and pharmaceutical enterprise engaged in the trading, distribution, and commercialization of pharmaceutical formulations, medical consumables, diagnostic supplies, and healthcare wellness products. The company operates across key business segments including Pharmaceuticals, Medical Consumables and Devices, Nutraceuticals, and Healthcare Supply Chain Services. Its comprehensive product and service portfolio comprises prescription pharmaceutical formulations, including generic antibiotics, analgesics, anti-inflammatory medications, oral solid dosage forms, capsules, syrups, and topical ointments; active pharmaceutical ingredients (APIs) and chemical intermediates for pharmaceutical manufacturing; medical devices and surgical consumables, such as disposable syringes, surgical gloves, IV infusion sets, wound care dressings, surgical sutures, and rapid diagnostic test kits; over-the-counter (OTC) healthcare products, including dietary supplements, vitamins, minerals, herbal extracts, and immunity boosters; and institutional procurement, warehousing, and healthcare logistics management services. Arvaya Healthcare serves a diversified client base consisting of government and private hospital networks, clinical laboratories, retail pharmacy chains, wholesale medical distributors, and outpatient healthcare centers across domestic Indian markets. In recent corporate developments, the company has undertaken strategic business restructuring and corporate rebranding to accelerate its expansion across high-growth healthcare segments. Over the past two years, Arvaya Healthcare has entered into strategic supply agreements with certified pharmaceutical manufacturers for third-party formulation production, introduced an expanded line of proprietary wellness and nutraceutical products, and broadened its regional logistics infrastructure to strengthen direct-to-institution medical supply operations. Headquartered in India and listed on the BSE under the ticker symbol ARVAYA, the company continues to scale its healthcare distribution network across urban and semi-urban markets.